Spanish pharmaceutical company Insud Pharma has established a specialized oligonucleotides center at its Chemo India Formulation Private Limited campus in Hyderabad. This center is dedicated to research and production of oligonucleotides, with the capacity to produce Nusinersen, an antisense oligonucleotide for treating Spinal Muscular Atrophy. It has received approvals from US FDA, Spanish Health Agency.
from Science News - Times of India https://ift.tt/5hgXQK6
Post Top Ad
Your Ad Spot
Thursday 14 September 2023
Home
Science
Science News - Times of India
Insud Pharma opens development & manufacturing centre for novel SMA oligonucleotide in Hyderabad
Insud Pharma opens development & manufacturing centre for novel SMA oligonucleotide in Hyderabad
Tags
Science#
Science News - Times of India#
Share This
About Sushil Kabira
Science News - Times of India
Labels:
Science,
Science News - Times of India
Subscribe to:
Post Comments (Atom)
Post Top Ad
Your Ad Spot
Author Details
Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat.
No comments:
Post a Comment